Related Experiment Video
Updated: Apr 10, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Neurologic Complications of Chronic Kidney Disease
Kavitha Vellanki1, Vinod K Bansal
1Department of Medicine, Division of Nephrology and Hypertension, Loyola University Medical Center, 2160 S. First Avenue, Bld 102 Room 3660, Maywood, IL, 60532, USA, kpotluri@lumc.edu.
Insights
Chronic kidney disease (CKD) increases stroke risk, especially with atrial fibrillation (AF). Anticoagulation in CKD may help prevent stroke but requires careful monitoring due to bleeding risks.
Area of Science:
- Nephrology
- Cardiology
- Neurology
Background:
- Chronic kidney disease (CKD) is a growing global health concern.
- CKD significantly elevates the risk of cardiovascular and cerebrovascular events, including stroke.
- Patients with end-stage renal disease (ESRD) have a 3-fold increased incidence of stroke.
Purpose of the Study:
- To review the relationship between CKD, atrial fibrillation (AF), and stroke risk.
- To discuss the complexities of anticoagulation therapy in CKD patients with AF.
- To highlight common neurological complications in CKD and their management.
Main Methods:
- Review of observational evidence on anticoagulation in CKD and AF.
- Analysis of neurological manifestations in CKD.
- Discussion of drug dosing and management strategies.
Main Results:
- Atrial fibrillation (AF) exacerbates stroke risk in CKD patients.
- Evidence on anticoagulation benefits for stroke prevention in CKD is conflicting due to high bleeding risks.
- Careful international normalized ratio (INR) monitoring is crucial for anticoagulation in CKD.
Conclusions:
- Anticoagulation may be beneficial for selected CKD patients with AF, provided meticulous INR monitoring.
- Neurological issues in CKD, such as those from electrolyte imbalances or uremia, require prompt diagnosis and management.
- Optimizing drug dosing and awareness of side effects are vital for reducing morbidity and mortality in CKD.
Abstract:
Chronic kidney disease (CKD) is an increasing problem worldwide and is now being recognized as a global health burden particularly for cardiovascular and cerebrovascular events. The incidence of stroke increases in the presence of CKD with a 3-fold increased rate reported in ESRD. Atrial fibrillation (AF) increases the risk of stroke in CKD. There is conflicting observational evidence regarding benefit of anticoagulation in CKD for prevention of stroke in AF as risk of bleeding is high. Overall, anticoagulant in CKD may be beneficial in appropriate patients with meticulous monitoring of international normalized ratio (INR). Neurological manifestations related to electrolyte disorders, drug toxicity, and uremia are common in CKD. Appropriate drug dosing, awareness of potential side effects of medications, prompt diagnosis, and treatment are essential in preventing long-term morbidity and mortality.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Acute Kidney Injury IV: Diagnostic Studies and Prevention

